Treatment for women with postpartum iron deficiency anaemia

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 12, 2013, Pages

  Markova, Veronika ^a   Nørgaard, Astrid ^a   Jørgensen, Karsten Juhl ^b   Langhoff Roos, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FOLIC ACID; IRON;

ARTICLE; BLOOD TRANSFUSION; CLINICAL EFFECTIVENESS; HUMAN; IRON DEFICIENCY ANEMIA; MINERAL SUPPLEMENTATION; PATIENT SAFETY; PRIORITY JOURNAL; PUERPERIUM; SYSTEMATIC REVIEW;

EID: 85041828637     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010861     Document Type: Article

References (48)

1. al-Momen AK, al-Meshari A, al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, et al.Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1996;69(2):121-4.
2. Almeida LC, Cardoso MA. Recommendations for folate intake in women: implications for public health strategies. Cadernos de saude publica 2010;26(11):2011-26. [PUBMED: 21180975]
3. Auerbach M, Goodnough LT, Picard D, Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion 2008;48(5):988-1000.
4. Barish CF, Koch T, Butcher A, Morris D, Bregman DB. Safety and efficacy of intravenous ferric carboxymaltose (750 mg) in the treatment of iron deficiency anemia: two randomized, controlled trials. Anemia 2012;2012:172104.
5. Barroso F, Allard S, Kahan BC, Connolly C, Smethurst H, Choo L, et al.Prevalence of maternal anaemia and its predictors: a multi-centre study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2011;159(1):99-105.
6. Bergmann RL, Richter R, Bergmann KE, Dudenhausen JW. Prevalence and risk factors for early postpartum anemia. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2010;150(2):126-31.
7. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG: an international journal of obstetrics and gynaecology 2006;113(11):1248-52.
8. Bodnar LM, Cogswell ME, Scanlon KS. Low income postpartum women are at risk of iron deficiency. Journal of Nutrition 2002;132(8):2298-302.
9. Bodnar LM, Cogswell ME, McDonald T. Have we forgotten the significance of postpartum iron deficiency?. American Journal of Obstetrics and Gynecology 2005;193(1):36-44.
10. Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. International Journal of Gynaecology and Obstetrics 2008;101(1):67-73.
11. Breymann C, Honegger C, Holzgreve W, Surbek D. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Archives of Gynecology and Obstetrics 2010;282(5):577-80.
12. Bunn HF. End run around epo. New England Journal of Medicine 2009; Vol. 361, issue 19:1901-3.
13. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD002042.pub3]
14. Dudrick SJ, O'Donnell JJ, Matheny RG, Unkel SP, Raleigh DP. Stimulation of hematopoiesis as an alternative to transfusion. Southern Medical Journal 1986;79(6):669-73.
15. Fuller AJ, Bucklin BA. Blood product replacement for postpartum hemorrhage. Clinical Obstetrics and Gynecology 2010;53(1):196-208.
16. Jan Brozek, Andrew Oxman, Holger Schünemann. GRADEpro. 3.2 for Windows. Jan Brozek, Andrew Oxman, Holger Schünemann, 2008.
17. Gupta SD, Khanna A, Gupta R, Sharma NK, Sharma ND. Maternal mortality ratio and predictors of maternal deaths in selected desert districts in Rajasthan a community-based survey and case control study. Womens Health Issues 2010;20(1):80-5.
18. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesthesia and Analgesia 2009;108(3):759-69.
19. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
20. Kennerley H, Gath D. Maternity blues. I. Detection and measurement by questionnaire. British Journal of Psychiatry 1989;155:356-62.
21. Khalafallah AA, Dennis AE. Iron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy. Journal of Pregnancy 2012;2012:630519.
22. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367(9516):1066-74.
23. Kliger AS, Fishbane S, Finkelstein FO. Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment. Clinical Journal of the American Society of Nephrology: CJASN 2012;7(2):354-7.
24. Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. Journal of Obstetrics and Gynaecology Research 2013;39(2):504-10.
25. Milman N. Postpartum anemia I: definition, prevalence, causes, and consequences. Annals of Hematology 2011;90(11):1247-53.
26. Milman N. Postpartum anemia II: prevention and treatment. Annals of Hematology 2012;91(2):143-54.
27. Oster HS, Neumann D, Hoffman M, Mittelman M. Erythropoietin: the swinging pendulum. Leukemia Research 2012;36(8):939-44.
28. Pena-Rosas JP, De-Regil LM, Dowswell T, Viteri FE. Daily oral iron supplementation during pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD004736.pub4]
29. Reveiz L, Gyte GML, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD003094.pub3]
30. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
31. Richter C, Huch A, Huch R. Erythropoiesis in the postpartum period. Journal of Perinatal Medicine 1995;23(1-2):51-9.
32. Schmitz N, Kruse J, Heckrath C, Alberti L, Tress W. Diagnosing mental disorders in primary care: the General Health Questionnaire (GHQ) and the Symptom Check List (SCL-90-R) as screening instruments. Social Psychiatry and Psychiatric Epidemiology 1999;34(7):360-6.
33. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology 2008;199(4):435.e1-7.
34. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50(4):753-65.
35. SHOT Steering Group. Annual SHOT report 2011. http://www.shotuk.org/wp-content/uploads/2012/07/SHOT-ANNUAL-REPORT_FinalWebVersionBookmarked_2012_06_22.pdf (accessed September 2013) 2011.
36. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstetrics and Gynecology 2007;110(2 Pt 1):267-78.
37. Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al.Transfusion strategies for acute upper gastrointestinal bleeding. New England Journal of Medicine 2013;368(1):11-21.
38. Ware JE Jr. SF-36 health survey update. Spine 2000;25(24):3130-9.
39. Westad S, Backe B, Salvesen KA, Nakling J, Okland I, Borthen I, et al.A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstetricia et Gynecologica Scandinavica 2008;87(9):916-23.
40. World Health Organization. Reduction of Maternal Mortality. A jointWHO/UNFPA/UNICEF/World Bank statement. Geneva: WHO, 1999.
41. World Health Organization. Iron Deficiency Anaemia - Assessment, Prevention, and Control WHO/NHD/01.3 2001. Geneva: WHO, 2001.
42. Rastogi T, Mathers C. Global burden of Iron Deficiency Anaemia in the year 2000. http://www.who.int/healthinfo/statistics/bod_irondeficiencyanaemia.pdf (accessed August 4 2013) 2002.
43. World Health Organization. Trends in maternal mortality: 1990 to 2010. WHO, UNICEF, UNFPA and The World Bank estimates. http://www.unfpa.org/webdav/site/global/shared/documents/publications/2012/Trends_in_maternal_mortality_A4-1.pdf (accessed September 2013) 2012.
44. World Health Organization. The WHO Application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: ICD-MM. http://apps.who.int/iris/bitstream/10665/70929/1/9789241548458_eng.pdf (accessed August 4 2013) 2012.
45. World Health Organization. International Classification of Diseases (ICD-10). http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf (accessed August 4 2013).
46. Wiesen AR, Hospenthal DR, Byrd JC, Glass KL, Howard RS, Diehl LF. Equilibration of hemoglobin concentration after transfusion in medical inpatients not actively bleeding. Annals of Internal Medicine 1994;121(4):278-30.
47. Wysowski DK, Swartz L, Borders-Hemphill BV, Goulding MR, Dormitzer C. Use of parenteral iron products and serious anaphylactic-type reactions. American Journal of Hematology 2010;85(9):650-4.
48. Dodd J, Dare MR, Middleton P. Treatment for women with postpartum iron deficiency anaemia. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD004222.pub2]